BioMarin Pharmaceutical Inc. is a world leader in developing and commercialising first- or best-in-class therapies for rare genetic diseases. BioMarin Pharmaceutical Inc. is looking for expertise in the pathology and epidemiology (highlighting a focus on clear genetic correlations) of rare skeletal diseases, alongside novel approaches for therapeutic intervention and technologies for targeted delivery to various cell types of the bone.
Comments are closed.